.png)
.png)
VP of Clinical Pharmacy & Research
Healix Infusion Therapy, LLC
Disclosure(s): Merck & Co.: Grant/Research Support; Paratek: Grant/Research Support
Lucinda J. Van Anglen, B.S., Pharm.D. is the Vice President of Clinical Pharmacy & Research. She joined Healix in 1994 and in her role is responsible for all phases of clinical research, both initiated research and in collaboration with the Healix-managed practices and infusion centers. Primary areas of interest are infectious disease, immunology and gastroenterology, with extensive real world and outcomes presentations, posters and publications. She also manages the clinical pharmacy department and pipeline for these areas, along with rheumatology and neurology. Her curriculum vitae also includes previous oversight of pharmacy operations for Healix, Assistant Professor and Clinical Coordinator at the University of Houston College of Pharmacy, acute care, ambulatory and pharma experience in infectious disease and nutritional support. Lucinda also worked as a Surveyor for the Joint Commission. She earned a Bachelor of Science degree in Pharmacy from the University of Nebraska Medical Center, completed her Pharmacy Practice Residency at Saint Marys Hospital in Rochester, Minnesota, part of the Mayo Clinic, and was awarded her post-baccalaureate Pharm.D. degree from the University of Utah.